Related references
Note: Only part of the references are listed.Impaired α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) Receptor Trafficking and Function by Mutant Huntingtin
Madhuchhanda Mandal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Brief ampakine treatments slow the progression of Huntington's disease phenotypes in R6/2 mice
Danielle A. Simmons et al.
NEUROBIOLOGY OF DISEASE (2011)
The Angelman Syndrome Protein Ube3A Regulates Synapse Development by Ubiquitinating Arc
Paul L. Greer et al.
CELL (2010)
Co-chaperone CHIP Stabilizes Aggregate-prone Malin, a Ubiquitin Ligase Mutated in Lafora Disease
Sudheendra N. R. Rao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Cognitive and Functional Decline in Huntington's Disease: Dementia Criteria Revisited
Guerry M. Peavy et al.
MOVEMENT DISORDERS (2010)
Loss of dopaminergic neurons and resulting behavioural deficits in mouse model of Angelman syndrome
Shalaka A. Mulherkar et al.
NEUROBIOLOGY OF DISEASE (2010)
Tissue-specific variation of Ube3a protein expression in rodents and in a mouse model of Angelman syndrome
Richard M. Gustin et al.
NEUROBIOLOGY OF DISEASE (2010)
Early Increase in Extrasynaptic NMDA Receptor Signaling and Expression Contributes to Phenotype Onset in Huntington's Disease Mice
Austen J. Milnerwood et al.
NEURON (2010)
Genomic imprinting of experience-dependent cortical plasticity by the ubiquitin ligase gene Ube3a
Masaaki Sato et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Early synaptic pathophysiology in neurodegeneration: insights from Huntington's disease
Austen J. Milnerwood et al.
TRENDS IN NEUROSCIENCES (2010)
Role of mitochondrial dysfunction in the pathogenesis of Huntington's disease
Rodrigo A. Quintanilla et al.
BRAIN RESEARCH BULLETIN (2009)
The Ubiquitin Ligase E6-AP Is Induced and Recruited to Aggresomes in Response to Proteasome Inhibition and May Be Involved in the Ubiquitination of Hsp70-bound Misfolded Proteins
Amit Mishra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
The ubiquitin ligase E6-AP promotes degradation of α-synuclein
Shalaka A. Mulherkar et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Ube3a is required for experience-dependent maturation of the neocortex
Koji Yashiro et al.
NATURE NEUROSCIENCE (2009)
Up-regulating BDNF with an ampakine rescues synaptic plasticity and memory in Huntington's disease knockin mice
Danielle A. Simmons et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
E6-AP promotes misfolded polyglutamine proteins for proteasomal degradation and suppresses polyglutamine protein aggregation and toxicity
Amit Mishra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Impaired ubiquitin-proteasome system activity in the synapses of Huntington's disease mice
Jianjun Wang et al.
JOURNAL OF CELL BIOLOGY (2008)
The Angelman syndrome ubiquitin ligase localizes to the synapse and nucleus, and maternal deficiency results in abnormal dendritic spine morphology
Scott V. Dindot et al.
HUMAN MOLECULAR GENETICS (2008)
Corticostriatal synaptic function in mouse models of Huntington's disease: early effects of huntingtin repeat length and protein load
Austen J. Milnerwood et al.
JOURNAL OF PHYSIOLOGY-LONDON (2007)
Transcriptional signatures in Huntington's disease
Jang-Ho J. Cha
PROGRESS IN NEUROBIOLOGY (2007)
Arc/Arg3.1 interacts with the endocytic machinery to regulate AMPA receptor trafficking
Shoaib Chowdhury et al.
NEURON (2006)
Arc/Arg3.1: Linking gene expression to synaptic plasticity and memory
Anastassios V. Tzingounis et al.
NEURON (2006)
The roles of intracellular protein-degradation pathways in neurodegeneration
David C. Rubinsztein
NATURE (2006)
Early development of aberrant synaptic plasticity in a mouse model of Huntington's disease
AJ Milnerwood et al.
HUMAN MOLECULAR GENETICS (2006)
Altered cortical glutamate receptor function in the r6/2 model of Huntington's disease
VM André et al.
JOURNAL OF NEUROPHYSIOLOGY (2006)
Diseases of unstable repeat expansion: Mechanisms and common principles
JR Gatchel et al.
NATURE REVIEWS GENETICS (2005)
Decreased expression of hypothalamic neuropeptides in Huntington disease transgenic mice with expanded polyglutamine-EGFP fluorescent aggregates
S Kotliarova et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington's disease
JM Van Raamsdonk et al.
JOURNAL OF NEUROSCIENCE (2005)
Co-chaperone CHIP associates with expanded polyglutamine protein and promotes their degradation by proteasomes
NR Jana et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Neurological aspects of the Angelman syndrome
CA Williams
BRAIN & DEVELOPMENT (2005)
Huntingtin and the molecular pathogenesis of Huntington's disease - Fourth in molecular medicine review series
C Landles et al.
EMBO REPORTS (2004)
Recent advances in understanding the pathogenesis of polyglutamine diseases: involvement of molecular chaperones and ubiquitin-proteasome pathway
NR Jana et al.
JOURNAL OF CHEMICAL NEUROANATOMY (2003)
Complex alteration of NMDA receptors in transgenic Huntington's disease mouse brain: analysis of mRNA and protein expression, plasma membrane association, interacting proteins, and phosphorylation
R Luthi-Carter et al.
NEUROBIOLOGY OF DISEASE (2003)
Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release
NR Jana et al.
HUMAN MOLECULAR GENETICS (2001)
Transcriptional dysregulation in Huntington's disease
JHJ Cha
TRENDS IN NEUROSCIENCES (2000)
Decreased expression of striatal signaling genes in a mouse model of Huntington's disease
R Luthi-Carter et al.
HUMAN MOLECULAR GENETICS (2000)
Share Paper
